The Barre-Montpelier Times Argus

4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics

Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for ...
Healio

FDA accepts IND for allogeneic CAR T-cell therapy that could bypass lymphodepletion

Please provide your email address to receive an email when new articles are posted on . The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen ...

AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD)

AB-1009 is an investigational gene therapy that has not been approved by any regulatory authority, and its efficacy and safety have not been established or fully evaluated. For more information, ...